Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Keyword is Research Design  [Clear All Filters]
A
Allen, JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, Tuff RA, Wilson KM, Mullen PD.  2010.  A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability.. Vaccine. 28(24):4027-37. Abstract
Arora, M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers MED, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M et al..  2011.  Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.. Blood. 117(24):6714-20. Abstract
Asgari, MM, Maruti SS, White E.  2008.  A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.. Journal of the National Cancer Institute. 100(13):967-71. Abstract
B
Ballard-Barbash, R, Hunsberger S, Alciati MH, Blair SN, Goodwin PJ, McTiernan A, Wing R, Schatzkin A.  2009.  Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations.. Journal of the National Cancer Institute. 101(9):630-43. Abstract
Bertelsen, L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B et al..  2008.  Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.. Journal of the National Cancer Institute. 100(1):32-40. Abstract
Bowen, DJ, Harris J, Jorgensen CM, Myers MF, Kuniyuki A.  2010.  Socioeconomic influences on the effects of a genetic testing direct-to-consumer marketing campaign.. Public health genomics. 13(3):131-42. Abstract
Bricker, JB, Peterson AV, Andersen MR, Sarason IG, Rajan BK, Leroux BG.  2007.  Parents' and older siblings' smoking during childhood: changing influences on smoking acquisition and escalation over the course of adolescence.. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 9(9):915-26. Abstract
C
Chaturvedi, AK, Madeleine MM, Biggar RJ, Engels EA.  2009.  Risk of human papillomavirus-associated cancers among persons with AIDS.. Journal of the National Cancer Institute. 101(16):1120-30. Abstract
Chia, VM, Newcomb PA, White E, Zheng Y, Potter JD, Lampe JW.  2008.  Reproducibility of serum leptin, insulin-like growth factor-I, and insulin-like growth factor-binding protein-3 measurements.. Hormone research. 69(5):295-300. Abstract
Chlebowski, RT, Prentice RL.  2008.  Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.. Journal of the National Cancer Institute. 100(19):1341-3.
Cook, MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L et al..  2010.  Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium.. Journal of the National Cancer Institute. 102(17):1344-53. Abstract
Corey, L, Nabel GJ, Dieffenbach C, Gilbert PB, Haynes BF, Johnston M, Kublin J, Lane CH, Pantaleo G, Picker LJ et al..  2011.  HIV-1 vaccines and adaptive trial designs.. Science translational medicine. 3(79):79ps13. Abstract
D
Donnell, D, Hughes JP, Fleming TR.  2010.  Challenges in the design of HIV prevention trials in the United States.. Journal of acquired immune deficiency syndromes (1999). 55 Suppl 2:S136-40. Abstract
Dorcy, KS.  2010.  Hegemony, hermeneutics, and the heuristic of hope.. ANS. Advances in nursing science. 33(1):78-90. Abstract
R
Roddam, AW, Allen NE, Appleby P, Key TJ.  2008.  Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.. Journal of the National Cancer Institute. 100(3):170-83. Abstract
E
Etzioni, R, Urban ND, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L.  2003.  The case for early detection.. Nature reviews. Cancer. 3(4):243-52. Abstract
G
Gilbert, PB, Qin L, Self SG.  2008.  Evaluating a surrogate endpoint at three levels, with application to vaccine development.. Statistics in medicine. 27(23):4758-78. Abstract
Gilbert, PB, Berger JO, Stablein D, Becker S, Essex M, Hammer SM, Kim JH, Degruttola VG.  2011.  Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.. The Journal of infectious diseases. 203(7):969-75. Abstract
Goldman, B, LeBlanc M, Crowley J.  2008.  Interim futility analysis with intermediate endpoints.. Clinical trials (London, England). 5(1):14-22. Abstract
Goodman, PJ, Tangen CM, Kristal AR, Thompson IM, Lucia SM, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML et al..  2010.  Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.. Cancer prevention research (Philadelphia, Pa.). 3(12):1523-33. Abstract
Goodman, GE, Alberts DS, Meyskens FL.  2008.  Retinol, vitamins, and cancer prevention: 25 years of learning and relearning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(34):5495-6.
Green, BB, Wang C-Y, Horner K, Catz S, Meenan RT, Vernon SW, Carrell D, Chubak J, Ko C, Laing S et al..  2010.  Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants.. Contemporary clinical trials. 31(6):589-603. Abstract
H
Hall, KL, Stokols D, Moser RP, Taylor BK, Thornquist MD, Nebeling LC, Ehret CC, Barnett MJ, McTiernan A, Berger NA et al..  2008.  The collaboration readiness of transdisciplinary research teams and centers findings from the National Cancer Institute's TREC Year-One evaluation study.. American journal of preventive medicine. 35(2 Suppl):S161-72. Abstract
Herbst, RS, Kelly K, Chansky K, Mack PC, Franklin WA, Hirsch FR, Atkins JN, Dakhil SR, Albain KS, Kim ES et al..  2010.  Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(31):4747-54. Abstract
Hoering, A, LeBlanc M, Crowley J.  2008.  Randomized phase III clinical trial designs for targeted agents.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(14):4358-67. Abstract